Skip to main content
. Author manuscript; available in PMC: 2015 Jan 30.
Published in final edited form as: Pharmacopsychiatry. 2012 Jun 14;46(1):29–34. doi: 10.1055/s-0032-1314843

Table 2.

Serotonin release by anti-inflammatory drugs and antidepressants.

A
10 min 60 min
control 10.1 ± 2.4 (14)− 5.1 ± 1.2 (12)−

citalopram 29.4± 5.4 (9)* 32.6±9.5 (8)**

ibuprofen 22.2±3.7 (9) ns 10.4± 1.9 (9) ns

indomethacin 34.3±7.0 (9) ns 25.7±6.7 (9)*

paroxetine 45.9±9.2 (10)*** 50.5±9.5 (7)***

sertraline 38.1 ± 6.4 (10)** 30.1 ± 8.6 (10)**
B
10 min 60 min
control + Ca2+ 25.7± 8.4(9)− 16.1 ±4.9(7)−

citalopram + Ca2+ 26.6±3.1 (4) ns 14.6± 1.8 (3) ns

ibuprofen + Ca2+ 59.1 ±22.5 (4)* 31.1 ± 13.1 (4) ns

indomethacin + Ca2+ 28.7±3.4 (4) ns 14.6±2.0 (4) ns

paroxetine + Ca2+ 96.7±38 (4)*** 34.8± 8.7 (2) ns

sertraline + Ca2+ 39.1 ±8.8 (6) ns 23.8± 5.4 (4) ns

Rat platelets were isolated from whole blood. Anti-inflammatory drugs or antidepressants without (A) or with (B) Ca2+ were added and platelets were incubated at 37 °C for 10 or 60 min. Supernatants were collected and serotonin was analyzed by HPLC-EC. Values are given as mean ± SEM % of total control. The number of analyzed samples is given in parenthesis. Statistical analysis was performed by one-way ANOVA with a Fisher LSD posthoc test.

*

p < 0.05

**

p < 0.01

***

p < 0.001; ns, not significant